Cite
HARVARD Citation
Tolaney, S. et al. (n.d.). Patients' quality of life and side effect perceptions in monarchE, a study of abemaciclib plus endocrine therapy in adjuvant treatment of HR+, HER2-, node-positive, high-risk, early breast cancer. Breast. pp. S20-S21. [Online].